Press Releases about Allakos Inc. - Common Stock![]() ![]()
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
October 10, 2024
From Allakos Inc.
Via GlobeNewswire
![]() From Allakos Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]()
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
February 12, 2024
From Allakos Inc.
Via GlobeNewswire
![]()
Allakos Announces a Restructuring to Focus on Development of AK006
January 16, 2024
From Allakos Inc.
Via GlobeNewswire
![]() ![]() From Allakos Inc.
Via GlobeNewswire
![]()
Allakos Appoints Neil Graham to its Board of Directors
August 30, 2023
From Allakos Inc.
Via GlobeNewswire
![]() From Allakos Inc.
Via GlobeNewswire
![]() From Allakos Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() From Allakos Inc.
Via GlobeNewswire
![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|